+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Quarterly Research Grant Funding Programme

Cure Parkinsons Trust

This programme funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief.Our grant funding process has changed! Due to the discontinuation of Grant Tracker, we will be returning to manual processes for research grant funding submissions. Please review all the guidance below for information on how to apply.Our funding remit

For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact us ahead of submission if you are thinking of applying for a clinical trial.

We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be justified and equivalent to academic costs where possible.

AI Based Application Success Predictor

1. Disease‑Modifying Focus

Projects must aim to slow, stop, or reverse Parkinson’s, not symptom relief.

Proposals should include the potential to translate into clinical use within 5 years, either via a Phase‑2/2b trial or critical supporting work .

📊 2. Pre‑clinical & Clinical Rigor

For preclinical projects, budgets typically go up to £250 K, with strong translational emphasis .

Clinical proposals may vary by size but must justify cost equivalence to academic standards and fall in the translational pathway .

🧭 3. Strategic Fit & Priorities

The Trust prioritizes disease‑modifying therapies, clinical trial readiness, and translational work linked to the International Linked Clinical Trials (iLCT) program .

All proposals go through the Research Committee and final trustee approval alongside funding availability and relevance .

📝 4. Expert Peer Review

Applications undergo 2+ external expert reviews followed by Research Committee assessment and Trustee sign-off .

The Trust is part of AMRC, guaranteeing a robust, peer-reviewed process .

🌍 5. Institutional & Commercial Support

Funding is open to academia and SMEs, with expectations for equivalent cost proposals in both cases .

The Trust funds globally, so international applicants are encouraged .

💰 6. Budget Transparency & No Overheads

Funds must only cover direct project costs, with no overheads upon overheads applied; grants have ranged from £50 K to £2.5 M over 1–3 years .

If co-funded, Cure Parkinson’s funding is contingent on securing the full budget overall .

⏱️ 7. Timely and Iterative Funding

Applications are accepted four times a year, with full assessment taking ~3–4 months .

Support is available for bridging funding—especially if trials face logistical delays .

🤝 8. Community & Networking

The Trust actively fosters connections between researchers, clinicians, patients, and stakeholders, including iLCT and workshops .

✅ Quick Success Checklist

Predictor	Why It’s Important
Disease‑modifying aim	Central to mission
≤5‑year clinical translation	Focused and urgent
Expert peer-reviewed design	Quality vetting
Institutional or SME backing	Feasibility and credibility
Transparent direct cost budget	Aligned with funding model
Completion roadmap & continuity	Realistic timelines
Committee/trustee endorsement	Strategic fit
Networking to iLCT & community	Greater visibility & support

💡 Tips to Optimize Your Application

Frame your project clearly as disease-modifying with a defined translation pathway within 5 years.

Detail scope, milestones, and direct costs thoroughly—avoid indirect expenses.

Show institutional or SME commitment, including resource support and cost justification.

Prepare for robust peer review: target high scientific rigor and translational potential.

Consider alignment with iLCT if researching repurposed compounds.

Plan reporting and possible bridging needs to avoid funding gaps.

Engage the Trust’s team early—they encourage pre-submission conversations.

Specialties

Neurosciences

Others

Eligibility Requirements

The RC evaluates applications (see process below) following our Research Strategy and using the following criteria:

• Appropriateness to CP’s core funding remit.

• Scientific rationale. • Originality.

• Clarity of the application.

• Experimental appropriateness.

• Appropriateness of statistical methods.

• Collaboration.

• Track record of applicant.

• Diversity considerations of animals or participants.

• Proposed budget and justification.

• Value for money.

• Proposed milestones.

• Overall quality of the application.

• The proximity of the proposal to clinical translation.

• The potential and likely impact of the project within a specified timescale.

• The steps needed to guide the project to clinic.

• Whether the project is a part of a wider programme of research.

• How you plan to share results and data broadly.

• Engagement and involvement of people with Parkinson’s in the project design process – this is assessed for both pre-clinical and clinical projects, please review the AMRC guidance that can be found here, or contact the CP research team for further support.

Sponsor Details

Sponsor Institute/Organizations: Cure Parkinsons Trust

Sponsor Type: Corporate/Non-Profit

Address: 120 New Cavendish Street, London W1W 6XX.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity